ginsenoside rh2 has been researched along with Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiaodan, S; Ying, C | 1 |
| Chen, N; Chu, S; Gao, Y; Hu, Y; Li, X; Lin, M; Liu, Y; Wang, H; Yang, S; Zhang, Y; Zhou, X | 1 |
| Bai, LP; Chan, KM; Chan, RW; Dong, H; Guo, J; Guo, Y; Hsiao, WW; Jiang, ZH; Kam, RK; Kong, AN; Law, BY; Leung, EL; Liang, X; Liu, L; Wang, J; Wang, R; Wong, VK; Yen, FG; Yu, Z; Zhang, W; Zhou, H | 1 |
| Lv, XH; Wang, Q; Wu, MQ; Yang, HK; Zhao, LH | 1 |
| Fang, X; Guo, X; He, K; Jin, YH; Li, Q; Li, Y; Sun, C; Wang, X; Zhan, Z | 1 |
2 review(s) available for ginsenoside rh2 and Neoplasms
| Article | Year |
|---|---|
Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation.
Topics: Ginsenosides; Immunomodulation; Neoplasms; Panax; Tumor Microenvironment | 2022 |
Anticancer property of ginsenoside Rh2 from ginseng.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Screening Assays, Antitumor; Ginsenosides; Humans; Neoplasms; Panax | 2020 |
3 other study(ies) available for ginsenoside rh2 and Neoplasms
| Article | Year |
|---|---|
Rh2E2, a novel metabolic suppressor, specifically inhibits energy-based metabolism of tumor cells.
Topics: Animals; Apoptosis; Azoxymethane; Carcinoma, Lewis Lung; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dextran Sulfate; Drugs, Chinese Herbal; Energy Metabolism; Ginsenosides; Humans; Immunoblotting; Mice, Inbred C57BL; Mitochondrial Proteins; Molecular Structure; Neoplasms; Proteomics; S Phase Cell Cycle Checkpoints | 2016 |
[Effect of ginsenoside Rh2 on transplanted-tumor and expression of JAM in mice].
Topics: Animals; Cell Adhesion Molecules; Drugs, Chinese Herbal; Female; Gene Expression Regulation; Ginsenosides; Immunoglobulins; Immunohistochemistry; Male; Mice; Neoplasm Transplantation; Neoplasms; Receptors, Cell Surface | 2008 |
Co-treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase-8 activation, bax translocation, and cytochrome c release.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Betulinic Acid; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Flow Cytometry; Ginsenosides; HeLa Cells; Hep G2 Cells; Humans; Molecular Structure; Neoplasms; Pentacyclic Triterpenes; Poly(ADP-ribose) Polymerases; Protein Transport; RNA Interference; Triterpenes | 2011 |